Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120729023 | 12072902 | 3 | F | 2016 | 20160628 | 20160212 | 20160706 | EXP | US-PFIZER INC-2016077846 | PFIZER | 86.00 | YR | F | Y | 64.00000 | KG | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120729023 | 12072902 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 2X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | BID | |||||||
| 120729023 | 12072902 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | ONE TABLET DAILY | 21845 | 1 | DF | FILM-COATED TABLET | ||||||||
| 120729023 | 12072902 | 3 | C | BUMETANIDE. | BUMETANIDE | 1 | 1 MG, 2X/DAY | 0 | 1 | MG | BID | ||||||||
| 120729023 | 12072902 | 4 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 UG, 1X/DAY | 0 | 1000 | UG | QD | |||||||
| 120729023 | 12072902 | 5 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 400 MG, 2X/DAY | 0 | 400 | MG | TABLET | BID | |||||||
| 120729023 | 12072902 | 6 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MEQ, 2X/DAY | 0 | 20 | MEQ | TABLET | BID | |||||||
| 120729023 | 12072902 | 7 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 120729023 | 12072902 | 8 | C | DILTIAZEM. | DILTIAZEM | 1 | 300 MG, DAILY (AT BEDTIME) | 0 | 300 | MG | TABLET | ||||||||
| 120729023 | 12072902 | 9 | C | INSULIN | INSULIN NOS | 1 | UNK | 0 | |||||||||||
| 120729023 | 12072902 | 10 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 325 MG, 1X/DAY | 0 | 325 | MG | TABLET | QD | |||||||
| 120729023 | 12072902 | 11 | C | Albuterol-Ipratropium | 2 | ALBUTEROL: 0.5MG-IPRATROPIUM: 3MG (2.5MG BASE/3ML) 3-4 PUFFS DAILY | 0 | ||||||||||||
| 120729023 | 12072902 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, DAILY | 0 | 20 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120729023 | 12072902 | 1 | Lung disorder |
| 120729023 | 12072902 | 2 | Dyspnoea |
| 120729023 | 12072902 | 3 | Diuretic therapy |
| 120729023 | 12072902 | 6 | Blood potassium decreased |
| 120729023 | 12072902 | 8 | Cardiac disorder |
| 120729023 | 12072902 | 9 | Diabetes mellitus |
| 120729023 | 12072902 | 10 | Abnormal faeces |
| 120729023 | 12072902 | 11 | Dyspnoea |
| 120729023 | 12072902 | 12 | Gastrointestinal disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120729023 | 12072902 | OT |
| 120729023 | 12072902 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120729023 | 12072902 | Bedridden | |
| 120729023 | 12072902 | Cough | |
| 120729023 | 12072902 | Dyspnoea | |
| 120729023 | 12072902 | Fatigue | |
| 120729023 | 12072902 | Intentional product use issue | |
| 120729023 | 12072902 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |